THE CODI Co.,LTD. (KOSDAQ:224060)

South Korea · Delayed Price · Currency is KRW

2,255.00

+100.00 (4.64%)

At close: Nov 13, 2026

Market Cap	11.58B -16.8%
Revenue (ttm)	22.73B -15.9%
Net Income	27.12B +105.7%
EPS	5,282.68 +98.6%
Shares Out	5.13M
PE Ratio	0.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,582
Open	2,135.00
Previous Close	2,155.00
Day's Range	2,135.00 - 2,350.00
52-Week Range	1,813.00 - 12,750.00
Beta	-0.08
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 19, 2027

About THE CODI Co.,LTD.

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified

Founded 1999

Employees 30

Stock Exchange KOSDAQ

Ticker Symbol 224060

Full Company Profile

Financial Performance

In 2025, THE CODI Co.,LTD.'s revenue was 25.27 billion, a decrease of -6.88% compared to the previous year's 27.13 billion. Earnings were 24.29 billion, an increase of 57.06%.

Financial Statements